Table:
begin	end	state
1	26	cytoplasmic
27	44	transmembrane
45	49	non-cytoplasmic
50	72	transmembrane
73	103	cytoplasmic
104	126	transmembrane
127	131	non-cytoplasmic
132	152	transmembrane
153	161	cytoplasmic
162	186	transmembrane
187	211	non-cytoplasmic
212	234	transmembrane
235	250	cytoplasmic
251	272	transmembrane
273	284	non-cytoplasmic
285	308	transmembrane
309	343	cytoplasmic
344	364	transmembrane
365	369	non-cytoplasmic
370	396	transmembrane
397	415	cytoplasmic
416	434	transmembrane
435	439	non-cytoplasmic
440	458	transmembrane
459	463	cytoplasmic

Input:
>WP_084934657.1 NCBI__GCF_002095475.1:WP_084934657.1
MVDQSKEALIEAEQPEKLRRNLHNRHIQLIAIGGAIGTGLFMGSGKTISLAGPSIIFVYM
IIGFMLFFVMRAMGELLLSNLEYKSFSDFAADLLGPWAGYFTGWTYWFCWVVTGIADVVA
ISAYFQLWFPGFSIWMSALLCIFAFLALNIATVKLFGEMEFWFAIIKIVAIVALIITGIV
LVSMHYPSPNGTTASLSNIWDHGGMFPKGLSGFFAGFQIAVFAFVGIELVGTAAAETKDP
HKVLPRAINAIPVRIIMFYVLALLVIMAVTPWNQVLPNRSPFVEMFVLIGLPAAASIVNF
VVLTSAASSANSGIFSTSRMLFGLAELGVAHKAFGRLSARAVPTTGLFFSCLCLLVGVAL
IYLIPDVMTVFTMVTTVSAILFMFVWTIILCSYLAYRKQHPQRHAASKFKMPLGKFMCWV
CMAFFAFVLVLLTLQEDTRQALMVTPLWFVILTLGWLLRRRKA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server